These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3016976)

  • 61. Interferon in nasal secretions and sera of calves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: association of interferon in nasal secretions with early resistance to challenge with virulent virus.
    Todd JD; Volenec FJ; Paton IM
    Infect Immun; 1972 May; 5(5):699-706. PubMed ID: 4344393
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge.
    Nobiron I; Thompson I; Brownlie J; Collins ME
    Vaccine; 2003 May; 21(17-18):2082-92. PubMed ID: 12706698
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Duration of immunity of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV, and BRSV in experimentally infected calves.
    Peters AR; Thevasagayam SJ; Wiseman A; Salt JS
    Prev Vet Med; 2004 Dec; 66(1-4):63-77. PubMed ID: 15579335
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detergent solubilised bovine viral diarrhea virus elicits a similar immune response as the inactivated virus.
    Mohanty JG; Elazhary Y; Talbot B
    Comp Immunol Microbiol Infect Dis; 1989; 12(4):129-37. PubMed ID: 2558836
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Failure of an in vitro lymphoproliferative assay specific for bovine herpes virus type 1 to detect immunised or latently infected animals.
    Wentink GH; Rutten VP; van Exsel AC; de Jong WA; Vleugel H; Hensen EJ
    Vet Q; 1990 Jul; 12(3):175-82. PubMed ID: 2171184
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A recombinant bovine herpesvirus 5 defective in thymidine kinase and glycoprotein E is immunogenic for calves and confers protection upon homologous challenge and BoHV-1 challenge.
    Anziliero D; Santos CM; Brum MC; Weiblen R; Chowdhury SI; Flores EF
    Vet Microbiol; 2011 Dec; 154(1-2):14-22. PubMed ID: 22019288
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
    Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of a neutralising antibody response to an inoculated cytopathic strain of bovine virus diarrhoea virus.
    Westenbrink F; Straver PJ; Kimman TG; de Leeuw PW
    Vet Rec; 1989 Sep; 125(10):262-5. PubMed ID: 2552639
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea.
    Cortese VS; Whittaker R; Ellis J; Ridpath JF; Bolin SR
    Am J Vet Res; 1998 Jul; 59(7):848-50. PubMed ID: 9659549
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of gastrointestinal parasites on parasite burden, rectal temperature, and antibody titer responses to vaccination and infectious bovine rhinotracheitis virus challenge.
    Schutz JS; Carroll JA; Gasbarre LC; Shelton TA; Nordstrom ST; Hutcheson JP; Van Campen H; Engle TE
    J Anim Sci; 2012 Jun; 90(6):1948-54. PubMed ID: 22648753
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neospora caninum in Estonian dairy herds in relation to herd size, reproduction parameters, bovine virus diarrhoea virus, and bovine herpes virus 1.
    Lassen B; Orro T; Aleksejev A; Raaperi K; Järvis T; Viltrop A
    Vet Parasitol; 2012 Nov; 190(1-2):43-50. PubMed ID: 22721941
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Production and study of the immunogenic properties of a bivalent inactivated vaccine against mucosal disease (bovine viral diarrhea and infectious rhinotracheitis)].
    Tsvetkov P; Petkova K; Bachiĭski L; Kharalambiev KhE
    Vet Med Nauki; 1979; 16(5):3-9. PubMed ID: 232586
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Response to modified live and killed multivalent viral vaccine in regularly vaccinated, fresh dairy cows.
    Dubovi EJ; Gröhn YT; Brunner MA; Hertl JA
    Vet Ther; 2000; 1(1):49-58. PubMed ID: 19757565
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnosis and Control of Viral Diseases of Reproductive Importance: Infectious Bovine Rhinotracheitis and Bovine Viral Diarrhea.
    Newcomer BW; Givens D
    Vet Clin North Am Food Anim Pract; 2016 Jul; 32(2):425-41. PubMed ID: 27140298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Virus neutralising antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves.
    Hamers C; Di Valentin E; Lecomte C; Lambot M; Joris E; Genicot B; Pastoret PP
    Vet J; 2002 Jan; 163(1):61-7. PubMed ID: 11749137
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neural changes in vaccinated calves challenge exposed with virulent infectious bovine rhinotracheitis virus.
    Narita M; Inui S; Nanba K; Shimizu Y
    Am J Vet Res; 1980 Dec; 41(12):1995-9. PubMed ID: 6259976
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
    Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
    Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
    Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
    Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.